Mereo BioPharma (MREO) Change in Account Payables (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Change in Account Payables for 3 consecutive years, with $447000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 46.98% to $447000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.4 million through Dec 2025, down 1043.84% year-over-year, with the annual reading at -$1.4 million for FY2025, 1043.84% down from the prior year.
  • Change in Account Payables for Q4 2025 was $447000.0 at Mereo BioPharma, up from -$236000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $987000.0 in Q4 2023, with the low at -$2.3 million in Q2 2023.
  • Average Change in Account Payables over 3 years is -$207916.7, with a median of $184000.0 recorded in 2024.
  • Peak annual rise in Change in Account Payables hit 185.04% in 2025, while the deepest fall reached 909.54% in 2025.
  • Over 3 years, Change in Account Payables stood at $987000.0 in 2023, then decreased by 14.59% to $843000.0 in 2024, then crashed by 46.98% to $447000.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $447000.0, -$236000.0, and -$2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.